Olympus Terumo Biomaterials - Ownership and Business Overview

Healthcare ServicesCompany

Olympus Terumo Biomaterials Ownership

Who owns Olympus Terumo Biomaterials?

Olympus Terumo Biomaterials is owned by Polaris Capital Group. It was acquired on May 27, 2024.

Is Olympus Terumo Biomaterials PE-backed?

Yes. Olympus Terumo Biomaterials is owned by private equity investor Polaris Capital Group.

Olympus Terumo Biomaterials Business Overview

Where is Olympus Terumo Biomaterials headquartered?

Olympus Terumo Biomaterials is headquartered in Tokyo, Japan.

What sector is Olympus Terumo Biomaterials in?

Olympus Terumo Biomaterials is a healthcare services company.

Healthcare Services M&A Summary in 2024

Out of 60 sectors in the Mergr database, healthcare services ranked 9 in number of deals in 2024. The largest healthcare services acquisition in 2024 was Retina Consultants of America - which was acquired by Cencora for $5.1B.

Join Mergr to view all 187 acquisitions of healthcare services companies in 2024, including 13 acquisitions by private equity firms, and 174 by strategics.

Olympus Terumo Biomaterials

Olympus Terumo Biomaterials Corp.

Daiwa Sasazuka Tower, 1-50-1 Sasazuka, Shibuya-ku,
Tokyo, 151-0073
Japan,
www.biomaterial.co.jp

Olympus Terumo Biomaterials operates an orthopedic surgery business in Japan, manufacturing and selling artificial bones, metal plates for HTO (high tibial osteotomy), and other related products. The company has a strong presence in the market through the provision of distinctive products in cervical spondylotic myelopathy. Olympus Terumo Biomaterials is based in Tokyo, Japan.


 Subscribe to unlock this and 208,718
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Olympus Terumo Biomaterials

Healthcare Services Companies , Japan Companies